Get the weekly note

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

EMB vs XLV: how they differ

EMB and XLV hold 0% of their weight in the same names, and XLV returned more over the year.

iShares J.P. Morgan USD Emerging Markets Bond ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.

What they hold in common

By the books each fund has filed, EMB and XLV hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in EMBOnly in XLV
Argentina Republic Government Internatio 1.12%Eli Lilly & Co 16.56%
Argentina Republic Government Internatio 0.73%Johnson & Johnson 10.67%
Argentina Republic Government Internatio 0.64%AbbVie Inc 7.76%
Argentina Republic Government Internatio 0.53%UnitedHealth Group Inc 6.59%
Uruguay Government International Bonds 0.52%Merck & Co Inc 5.54%
EAGLE FUNDING LUXCO SARL 0.51%Amgen Inc 3.41%
Republic of Poland Government Internatio 0.40%Thermo Fisher Scientific Inc 3.25%
UKRAINE GOVERNMENT 0.38%Abbott Laboratories 2.76%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.

EMB and XLV on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
EMB
iShares J.P. Morgan USD Emerging Markets Bond ETF
XLV
State Street(R) Health Care Select Sector SPDR(R) ETF
Where it sitsCore index fundCore index fund
IssueriSharesState Street
What it isJ.P. Morgan USD Emerging Markets BondHealth care
Total return, 1 year+2.8%+20.4%
S&P 500 over the same days+17.5%+17.5%
Gap to the S&P 500−14.7 pts+2.9 pts
Expense ratio0.39%0.08%
Holdings68159

EMB in plain words

EMB is a bond fund tracking the J.P. Morgan USD Emerging Markets Bond. Over the year to Sep 11, 2026 it returned +2.8% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.39% a year.

XLV in plain words

XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, EMB or XLV?
In the year to Sep 12, 2026, with distributions reinvested, EMB returned +2.8% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
Which is cheaper, EMB or XLV?
EMB charges 0.39% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

EMB against XLV, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, EMB against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/EMB-XLV Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources